(1S,6S)-1,6-Bis((diphenylphosphanyl)oxy)spiro[4.4]nonane

Catalog No. :
ACLBBM079
CAS No. :
197252-01-0
Molecular Formula :
C33H34O2P2
Molecular Weight :
524.58

IUPAC Name:(1S,6S)-1,6-bis((diphenylphosphaneyl)oxy)spiro[4.4]nonane

(1S,6S)-1,6-Bis((diphenylphosphanyl)oxy)spiro[4.4]nonane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,6S)-1,6-Bis((diphenylphosphanyl)oxy)spiro[4.4]nonane
IUPAC Name(1S,6S)-1,6-bis((diphenylphosphaneyl)oxy)spiro[4.4]nonane
Molecular FormulaC33H34O2P2
Molecular Weight524.58
SMILESC1=CC=C(P(O[C@H]2CCCC23CCC[C@@H]3OP(C2=CC=CC=C2)C2=CC=CC=C2)C2=CC=CC=C2)C=C1
InChI KeyPCHVGYNFFQCAEB-KOPQTXDBSA-N
SynonymCTH-(S)-SPIROP;min.cth-(s)-spirop;1S,5S,6S-(-)-1,6-Bis(diphenylphosphinoxy)spiro[4.4]nonane,min.95%CTH-(S)-SpiroP;1s,5s,6s-(-)-1,6-bis(diphenylphosphinoxy)spiro[4.4]nonane, cth-(s)-spirop;1S,5S,6S-(-)-1,6-Bis(diphenylphosphinoxy)spiro[4.4]nonane Application: Asymmetric hydrogenation StoreN2Ar;1S,5S,6S-(-)-1,6-Bis(diphenylphosphinoxy)spiro4.4ünonane, CTH-(S)-SpiroP, 95%;1S,5S,6S-(-)-1,6-Bis(diphenylphosphinoxy)spiro4.4ünonane;1S,5S,6S-(-)-1,6-BIS(DIPHENYLPHOSPHINOXY)SPIRO[4.4]NONANE
CAS No.197252-01-0

Synthetic Route by SureRoute

1. ACLBBM079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLBBM079 route product structure diagram
    ACLBBM079197252-01-0
Inquiry

2. ACLBBM079 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACLBBM079 route product structure diagram
    ACLBBM079197252-01-0
Inquiry

Comments (0)